Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 79
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Gupta, Swapnil Ranganathan, Mohini and D’Souza, Deepak Cyril 2016. The early identification of psychosis: can lessons be learnt from cardiac stress testing?. Psychopharmacology, Vol. 233, Issue. 1, p. 19.

    Weibell, Melissa A. ten Velden Hegelstad, Wenche and Johannessen, Jan Olav 2016. Neuropathology of Drug Addictions and Substance Misuse.

    El-Khoury, Joseph and Sahakian, Nayiri 2015. The Association ofSalvia divinorumand Psychotic Disorders: A Review of the Literature and Case Series. Journal of Psychoactive Drugs, Vol. 47, Issue. 4, p. 286.

    Shakoor, Sania Zavos, Helena M.S. McGuire, Philip Cardno, Alastair G. Freeman, Daniel and Ronald, Angelica 2015. Psychotic experiences are linked to cannabis use in adolescents in the community because of common underlying environmental risk factors. Psychiatry Research, Vol. 227, Issue. 2-3, p. 144.

    Testa, Maria and Brown, Whitney C 2015. Does marijuana use contribute to intimate partner aggression? A brief review and directions for future research. Current Opinion in Psychology, Vol. 5, p. 6.

    Black, Shimrit K. de Moor, Carl Kendall, Ashley D. and Shrier, Lydia A. 2014. Feasibility of Momentary Sampling Assessment of Cannabis Use in Adolescents and Young Adults. Journal of Child & Adolescent Substance Abuse, Vol. 23, Issue. 3, p. 177.

    Renard, Justine Krebs, Marie-Odile Le Pen, Gwenaëlle and Jay, Thérèse M. 2014. Long-term consequences of adolescent cannabinoid exposure in adult psychopathology. Frontiers in Neuroscience, Vol. 8,

    van Gastel, W.A. Vreeker, A. Schubart, C.D. MacCabe, J.H. Kahn, R.S. and Boks, M.P.M. 2014. Change in cannabis use in the general population: A longitudinal study on the impact on psychotic experiences. Schizophrenia Research, Vol. 157, Issue. 1-3, p. 266.

    Tournier, M. 2013. Premiers épisodes psychotiques : actualités cliniques et épidémiologiques. L'Encéphale, Vol. 39, p. S74.

    Anglin, Deidre M. Corcoran, Cheryl M. Brown, Alan S. Chen, Henian Lighty, Quenesha Brook, Judith S. and Cohen, Patricia R. 2012. Early cannabis use and Schizotypal Personality Disorder Symptoms from adolescence to middle adulthood. Schizophrenia Research, Vol. 137, Issue. 1-3, p. 45.

    Fraser, Samantha Hides, Leanne Philips, Lisa Proctor, Dawn and Lubman, Dan I. 2012. Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people. Schizophrenia Research, Vol. 136, Issue. 1-3, p. 110.

    Kimhy, D. Myin-Germeys, I. Palmier-Claus, J. and Swendsen, J. 2012. Mobile Assessment Guide for Research in Schizophrenia and Severe Mental Disorders. Schizophrenia Bulletin, Vol. 38, Issue. 3, p. 386.

    Konings, M. Stefanis, N. Kuepper, R. de Graaf, R. Have, M. ten van Os, J. Bakoula, C. and Henquet, C. 2012. Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk. Psychological Medicine, Vol. 42, Issue. 01, p. 149.

    Ben-Zeev, D. Ellington, K. Swendsen, J. and Granholm, E. 2011. Examining a Cognitive Model of Persecutory Ideation in the Daily Life of People With Schizophrenia: A Computerized Experience Sampling Study. Schizophrenia Bulletin, Vol. 37, Issue. 6, p. 1248.

    Casadio, Paola Fernandes, Cathy Murray, Robin M. and Di Forti, Marta 2011. Cannabis use in young people: The risk for schizophrenia. Neuroscience & Biobehavioral Reviews, Vol. 35, Issue. 8, p. 1779.

    Estrada, G. Fatjó-Vilas, M. Muñoz, M. J. Pulido, G. Miñano, M. J. Toledo, E. Illa, J. M. Martín, M. Miralles, M. L. Miret, S. Campanera, S. Bernabeu, C. Navarro, M. E. and Fañanás, L. 2011. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatrica Scandinavica, Vol. 123, Issue. 6, p. 485.

    Habets, Petra Marcelis, Machteld Gronenschild, Ed Drukker, Marjan and van Os, Jim 2011. Reduced Cortical Thickness as an Outcome of Differential Sensitivity to Environmental Risks in Schizophrenia. Biological Psychiatry, Vol. 69, Issue. 5, p. 487.

    Martinotti, Giovanni Di Iorio, Giuseppe Tedeschi, Daniela De Berardis, Domenico Niolu, Cinzia Janiri, Luigi and Di Giannantonio, Massimo 2011. Prevalence and intensity of basic symptoms among cannabis users: an observational study. The American Journal of Drug and Alcohol Abuse, Vol. 37, Issue. 2, p. 111.

    McGrath, John J. and Murray, Robin M. 2011. Schizophrenia.

    Palmier-Claus, J. E. Myin-Germeys, I. Barkus, E. Bentley, L. Udachina, A. Delespaul, P. A. E. G. Lewis, S. W. and Dunn, G. 2011. Experience sampling research in individuals with mental illness: reflections and guidance. Acta Psychiatrica Scandinavica, Vol. 123, Issue. 1, p. 12.


Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study

  • H. VERDOUX (a1), C. GINDRE (a1), F. SORBARA (a1), M. TOURNIER (a1) and J. D. SWENDSEN (a1)
  • DOI:
  • Published online: 01 January 2003

Background. Epidemiological findings suggest that cannabis use is a risk factor for the emergence of psychosis, and that the induction of psychotic symptoms in the context of cannabis use may be associated with a pre-existing vulnerability for psychosis. This study investigated in a non-clinical population the interaction between cannabis use and psychosis vulnerability in their effects on psychotic experiences in daily life.

Method. Subjects (N = 79) with high or low levels of cannabis use were selected among a sample of 685 undergraduate university students. Experience sampling method (ESM) was used to collect information on substance use and psychotic experiences in daily life. Vulnerability to develop psychosis was measured using a clinical interview assessing the level of psychotic symptoms. Statistical analyses were performed using multilevel linear random regression models.

Results. The acute effects of cannabis are modified by the subject's level of vulnerability for psychosis. Subjects with high vulnerability for psychosis are more likely to report unusual perceptions as well as feelings of thought influence than subjects with low vulnerability for psychosis, and they are less likely to experience enhanced feelings of pleasure associated with cannabis. There is no evidence that use of cannabis is increased following occurrence of psychotic experiences as would be expected by the self-medication model.

Conclusion. Cannabis use interacts with psychosis vulnerability in their effects on experience of psychosis in daily life. The public health impact of the widespread use of cannabis may be considerable.

Corresponding author
Address for correspondence: Professor Hélène Verdoux, Hôpital Charles Perrens, 121 rue de la Béchade, 33076 Bordeaux Cedex, France.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *